 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
3-17-2014
Insider Buy |
Erle T. Mast
Director |
$50.67
CAGR »
|
$15,200.20
300 shares |
5-14-2013
Insider Buy |
Eli & CO Lilly
>10% Owner |
$14.00
CAGR »
|
$1,999,998.00
142,857 shares |
5-14-2013
Insider Buy |
Associates V. LP Venrock
>10% Owner |
$14.00
CAGR »
|
$3,717,938.00
265,567 shares |
5-14-2013
Insider Buy |
S. Edward Torres
Director |
$14.00
CAGR »
|
$1,999,998.00
142,857 shares |
5-14-2013
Insider Buy |
Kristina Burow
Director |
$14.00
CAGR »
|
$3,982,790.00
284,485 shares |
5-14-2013
Insider Buy |
William H. Rastetter
Director |
$14.00
CAGR »
|
$4,717,930.00
336,995 shares |
5-14-2013
Insider Buy |
Flagship Ventures Fund 2007, L.P.
>10% Owner |
$14.00
CAGR »
|
$1,499,988.00
107,142 shares |
5-14-2013
Insider Buy |
Venture Fund Vii LP Arch
>10% Owner |
$14.00
CAGR »
|
$3,982,790.00
284,485 shares |
5-14-2013
Insider Buy |
Lilly Ventures Fund I LLC
>10% Owner |
$14.00
CAGR »
|
$1,999,998.00
142,857 shares |
Also See: Institutional Holders of RCPT
Also See: SEC filings
Below we present the annualized performance delivered by Receptos stock since 3-17-2014 (the date of the most recent
insider purchase). The performance of the investment from the time Receptos insider buying occurred is the ultimate
test of whether insiders were right about RCPT being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
03/18/2014 |
|
| End date: |
08/27/2015 |
|
| Start price/share: |
$53.78 |
|
| End price/share: |
$231.96 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
331.31% |
|
| Average Annual Total Return: |
175.21% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$43,132.32 |
|
| Years: |
1.44 |
|
Receptos Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent Receptos insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding RCPT
|
|
Free RCPT Email Alerts:
